X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (612) 612
Publication (74) 74
Patent (13) 13
Book Chapter (6) 6
Conference Proceeding (4) 4
Book Review (3) 3
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (323) 323
male (226) 226
index medicus (185) 185
female (181) 181
bladder cancer (176) 176
oncology (166) 166
urology & nephrology (166) 166
aged (157) 157
middle aged (157) 157
urinary bladder neoplasms - pathology (154) 154
cancer (146) 146
urology (144) 144
cystectomy (85) 85
urinary bladder neoplasms - genetics (80) 80
urinary bladder neoplasms - surgery (77) 77
adult (76) 76
prognosis (72) 72
neoplasm staging (70) 70
retrospective studies (70) 70
aged, 80 and over (69) 69
urinary bladder neoplasms - drug therapy (69) 69
chemotherapy (64) 64
carcinoma (63) 63
animals (61) 61
carcinoma, transitional cell - pathology (61) 61
risk factors (58) 58
care and treatment (55) 55
mice (55) 55
article (54) 54
survival (54) 54
treatment outcome (54) 54
transitional-cell carcinoma (53) 53
neoplasm invasiveness (52) 52
radical cystectomy (52) 52
urothelial carcinoma (51) 51
urinary bladder neoplasms - therapy (47) 47
carcinoma, transitional cell - surgery (45) 45
urinary bladder neoplasms - mortality (45) 45
expression (44) 44
recurrence (44) 44
tumors (42) 42
urinary bladder neoplasms - metabolism (41) 41
metastasis (39) 39
research (38) 38
mice, nude (37) 37
risk (37) 37
abridged index medicus (36) 36
survival rate (36) 36
cystectomy - methods (35) 35
immunohistochemistry (34) 34
urinary-bladder (34) 34
bladder (31) 31
carcinoma, transitional cell - drug therapy (31) 31
health aspects (31) 31
analysis (30) 30
bladder-cancer (30) 30
cell line, tumor (30) 30
disease-free survival (30) 30
surgery (30) 30
transitional-cell-carcinoma (29) 29
disease progression (28) 28
case-control studies (27) 27
combined modality therapy (27) 27
time factors (26) 26
urinary bladder (26) 26
genetic predisposition to disease (25) 25
neoadjuvant chemotherapy (25) 25
follow-up studies (24) 24
lung-cancer (24) 24
chemotherapy, adjuvant (23) 23
genotype (23) 23
patient outcomes (23) 23
polymorphism, single nucleotide (23) 23
urinary bladder neoplasms - diagnosis (23) 23
carcinoma, transitional cell - mortality (22) 22
diagnosis (22) 22
gene expression regulation, neoplastic (22) 22
genetic aspects (22) 22
kaplan-meier estimate (22) 22
progression (22) 22
adenocarcinoma (21) 21
adjuvant treatment (21) 21
cisplatin (21) 21
lymphatic metastasis (21) 21
neoplasm metastasis (21) 21
nude-mice (21) 21
survival analysis (21) 21
tumor cells, cultured (21) 21
administration, intravesical (20) 20
apoptosis (20) 20
mice, inbred balb c (20) 20
multivariate analysis (20) 20
neoadjuvant therapy (20) 20
kidney neoplasms - pathology (19) 19
medicine & public health (19) 19
methotrexate (19) 19
outcomes (19) 19
breast-cancer (18) 18
carcinoma, transitional cell - metabolism (18) 18
invasive bladder-cancer (18) 18
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Cell, ISSN 1535-6108, 02/2014, Volume 25, Issue 2, pp. 152 - 165
Muscle-invasive bladder cancers (MIBCs) are biologically heterogeneous and have widely variable clinical outcomes and responses to conventional chemotherapy.... 
BREAST-CANCER | CELLS | ONCOLOGY | PROGNOSIS | UROTHELIAL CARCINOMA | RADICAL CYSTECTOMY | GENE-EXPRESSION | CLASSIFICATION | MICROARRAYS | P63 | PROGRESSION | CELL BIOLOGY | Receptors, Estrogen - metabolism | Urinary Bladder Neoplasms - classification | Cell Proliferation | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Muscle Neoplasms - pathology | Muscle Neoplasms - classification | Male | Gene Expression Profiling | Vinblastine - administration & dosage | PPAR gamma - metabolism | Receptor, Fibroblast Growth Factor, Type 3 - metabolism | Tumor Suppressor Protein p53 - genetics | Cisplatin - administration & dosage | Urinary Bladder Neoplasms - pathology | Female | Neoadjuvant Therapy | Cell Differentiation | Muscle Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | Doxorubicin - administration & dosage | PPAR gamma - genetics | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Receptors, Estrogen - genetics | Neoplasm Invasiveness | RNA, Messenger - genetics | Carcinoma, Basal Cell - pathology | Urinary Bladder Neoplasms - drug therapy | Mutation - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Drug Resistance, Neoplasm - genetics | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Basal Cell - drug therapy | Methotrexate - administration & dosage | Aged | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Neoplasm Staging | Clinical Trials, Phase II as Topic | Cohort Studies | Chemotherapy | Anthracyclines | Estrogen | Methotrexate | Tumor proteins | Bladder cancer | Cancer
Journal Article
Cancer, ISSN 0008-543X, 06/2014, Volume 120, Issue 12, pp. 1794 - 1799
Journal Article
Journal Article
Journal of Urology, The, ISSN 0022-5347, 2014, Volume 191, Issue 1, pp. 40 - 47
Journal Article
Journal Article
by Garcia-Closas, M and Chatterjee, N and Malats, N and Wu, X and Figueroa, J.D and Real, F.X and Berg, D. Van den and Matullo, G and Baris, D and Thun, M and Kiemeney, L.A.L.M and Vilneis, P and De Vivo, I and Albanes, D and Purdue, M and Rafnar, T and Hildebrandt, M.A.T and Kiltie, A.E and Cussenot, O and Golka, K and Kumar, R and Taylor, J.A and Mayordomo, J.I and Jacobs, K.B and Kogevinas, M and Hutchinson, A and Wang, Z and Fu, Y and Prokunina-Olsson, L and Burdett, L and Yeager, M and Wheeler, W and Tardon, A and Serra, C and Carrato, A and Garcia-Closas, R and Lloreta, J and Johnson, A and Schwenn, M and Karagas, M.R and Schned, A and Aniole, G.L and Grubb, R and Black, A and Jacobs, E.J and Diver, W.R and Gapstur, S.M and Weinstein, S.J and Virtamo, J and Cortessis, V.K and Gago-Dominguez, M and Pike, M.C and Stern, M.C and Yuan, J.M and Hunter, D.J and McGrath, M and Dinney, C.P and Czerniak, B and Chen, M and Yang, H and Vermeulen, S and Aben, K.K.H and Witjes, J.A and Makkinje, R.R and Sulem, P and Besenbacher, S and Riboli, E and Brennan, P and Panico, S and Navarro, C and Allen, N.E and Bueno-De-Mesquita, H.B and Trichopoulos, D and Caporaso, N and Landi, M.T and Canzian, F and Ljungberg, B and Tjonneland, A and Clavel-Chapelon, F and Bishop, D.T and Teo, M.T and Knowles, M.A and Guarrera, S and Polidoro, S and Ricceri, F and Sacerdote, C and Allione, A and Cancel-Tassin, G and Selinski, S and Hengstler, J.G and Dietrich, H and Fletcher, T and Rudnai, P and Gurzau, E and Koppova, K and Bolick, S.C and Godfrey, A and Xu, Z and Medicinska fakulteten and Urologi och andrologi and Institutionen för kirurgisk och perioperativ vetenskap and Umeå universitet
Nature Genetics, ISSN 1061-4036, 2010, Volume 42, Issue 11, pp. 978 - 984
We conducted a multi-stage, genome-wide association study of bladder cancer with a primary scan of 591,637 SNPs in 3,532 affected individuals (cases) and 5,120... 
Smoking - adverse effects | United States - epidemiology | Arylamine N-Acetyltransferase - metabolism | Humans | Male | Incidence | Chromosomes, Human, Pair 2 - genetics | Chromosomes, Human, Pair 22 - genetics | Urinary Bladder Neoplasms - genetics | Chromosome Mapping - methods | Urinary Bladder Neoplasms - pathology | Female | Urinary Bladder Neoplasms - epidemiology | Genetic Predisposition to Disease | Genome-Wide Association Study | Risk Assessment | Risk Factors | Europe - epidemiology | Sex Characteristics | Spain - epidemiology | Family | Arylamine N-Acetyltransferase - genetics | Polymorphism, Single Nucleotide | Chromosomes, Human, Pair 18 - genetics | Neoplasm Staging | CONFERS SUSCEPTIBILITY | COMMON VARIANTS | UDP-GLUCURONOSYLTRANSFERASES | SEQUENCE VARIANT | POLYMORPHISMS | GENE | TELOMERASE MUTATIONS | GENETICS & HEREDITY | DOWN-REGULATION | RISK | STRATIFICATION | Quantitative trait loci | Genetic aspects | Disease susceptibility | Research | Bladder cancer | Studies | Genotype & phenotype | Family medical history | Chromosomes | Cancer | Tumors | Index Medicus | Genome-wide association studies | Psychology | Basic Medicine | Medical Genetics | Medicinsk genetik | Medical and Health Sciences | Medicin och hälsovetenskap | Medicinska och farmaceutiska grundvetenskaper | confers susceptibility; udp-glucuronosyltransferases; recombination hotspots; telomerase mutations; pulmonary-fibrosis; sequence variant; common variants; chromosome 8q24; down-regulation; cell-carcinoma
Journal Article
Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 2013, Volume 31, Issue 8, pp. 1635 - 1642
Journal Article
Journal Article
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 10/2017, Volume 35, Issue 30, pp. 3410 - 3410
Journal Article